Literature DB >> 31368103

Aldehyde Dehydrogenase (ALDH) 2 in Diabetic Heart Diseases.

Srikar Munukutla1, Guodong Pan1, Suresh S Palaniyandi2,3.   

Abstract

A major pathophysiological mechanism behind the development of diabetic heart diseases is oxidative stress mediated by toxic reactive aldehydes such as 4-hydroxynonenal (4HNE). Aldehyde dehydrogenase (ALDH) 2 is a mitochondrial enzyme that has been found to detoxify these deleterious aldehydes and thereby mitigate cardiac damage. Furthermore, its protective role in cellular signaling reverses aberrations caused by hyperglycemia, thereby protecting cardiac function. This chapter assesses the role of ALDH2 in diabetic heart diseases by examining preclinical studies where ALDH2 activity is perturbed in both decreased and increased directions. In doing so, issues in improving ALDH2 activity in select human populations are elucidated, and further research directions are discussed.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31368103     DOI: 10.1007/978-981-13-6260-6_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications.

Authors:  Sravya Jannapureddy; Mira Sharma; Gautham Yepuri; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-11       Impact factor: 5.555

2.  Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression.

Authors:  Yue Wang; Kangshuai Li; Wei Zhao; Zengli Liu; Jialiang Liu; Anda Shi; Tianli Chen; Wentao Mu; Yunfei Xu; Chang Pan; Zongli Zhang
Journal:  Cell Death Dis       Date:  2021-12-14       Impact factor: 8.469

3.  Prospective study: Aldehyde dehydrogenase 2 gene is associated with cardio-cerebrovascular complications in type 2 diabetes patients.

Authors:  Qingfang He; Jin Pan; Lixin Wang; Yujia Fang; Ruying Hu
Journal:  J Diabetes Investig       Date:  2021-04-09       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.